Who is sponsoring NCT04985188?

NCT04985188 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT04985188?

Interventions in NCT04985188: Quantitative ultrasound (QUS) technique.

What condition does NCT04985188 study?

NCT04985188 studies Diagnoses Disease.

Is NCT04985188 still recruiting?

NCT04985188 is currently status unknown. Last updated 2 August 2021.

Last reviewed 2021-08-02 · How we verify

NCT04985188

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quantitative Ultrasound for Diagnosing Hepatic Steatosis in Nonalcoholic Fatty Liver Multicenter Study

Status unknown Last updated 2 August 2021

What this trial tests

trial testing Quantitative ultrasound (QUS) technique in Diagnoses Disease in 112 participants. Status unknown.

Timeline

12 August 2021

Primary endpoint
31 July 2022

31 December 2022

Quick facts

Lead sponsor	Seoul National University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	112
Start date	12 August 2021
Primary completion	31 July 2022
Estimated completion	31 December 2022

Drugs / interventions tested

Quantitative ultrasound (QUS) technique

Conditions studied

Diagnoses Disease — all drugs for Diagnoses Disease →

Sponsor

Seoul National University Hospital

Who can join

18 and older, any sex, with Diagnoses Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the diagnostic performance of quantitative ultrasound parameters for assessing hepatic steatosis in non-alcoholic fatty liver disease using histologic results as reference standard

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Metabolic Dysfunction-Associated Steatotic Liver Disease at Quantitative US: International Prospective Study.
Huang TY, Li ZY, Tian J, Xie XJ, et al · · 2025 · cited 1× · PMID 40662970 · DOI 10.1148/radiol.242564

Verify or expand the search:

Other recruiting trials for Diagnoses Disease

Currently open trials in the same condition.

NCT06439901 — Optimizing Bronchopulmonary Cancer Screening · NA · recruiting
NCT04536220 — Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer · recruiting
NCT04567368 — TB-CAPT MTB/XDR Study · active not recruiting
NCT06616506 — Artificial Intelligence for Highly Myopic Cataract · recruiting

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04985188 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 2 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04985188.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing